JNJ-10166806

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameJNJ-10166806

Drug Alias NameRXR modulator (Johnson & Johnson)RXR modulator (Johnson & Johnson)retinoid X receptor modulator (Johnson & Johnson)retinoid X receptor modulator (Johnson & Johnson)JNJ-10166806

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionInsulin sensitizersRetinoid X receptor modulators

TargetsRetinoid X receptor

Therapy Area/IndicationsSyndromeDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesJohnson & Johnson Pharmaceutical Research & Development LLC

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesJohnson & Johnson Pharmaceutical Research & Development LLC

Active IndicationsN/A

Inactive IndicationsSyndromeDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A